RaphaelEricSteinerMD

PubMed

• International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
  Michael Sargent Binkley, Jamie E Flerlage, Kerry J Savage, Saad Akhtar, Raphael Steiner, Xiao-Yin Zhang, Michael Dickinson, Anca Prica, Ajay Major, Peter G Hendrickson...> ;Journal of Clinical Oncology. 2024 Mar 26
• 1 citations
  Impact of cumulative dose of brentuximab vedotin on outcomes of frontline therapy for advanced-stage Hodgkin lymphoma.
  Steiner, R., Hwang, S., Khurana, A., Habermann, T., Epperla, N., Annunzio, K., Allen, P., Baird, K., Paulino, D., Alderuccio, J., Lossos, I., David, K., Evens, A., Pan...> ;Blood Advances. 2023 Dec 26
• Effect of delayed cell infusion in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy.
  Andrew P Jallouk, Naishu Kui, Ryan Sun, Jason R Westin, Raphael E Steiner, Ranjit Nair, Loretta J Nastoupil, Luis E Fayad, Ajlan Al Zaki, Misha Hawkins, Sherry Adkins,...> ;Haematologica. 2023 Nov 30
• Real-world analysis of safety and efficacy of CAR T-cell therapy in lymphoma patients with decreased kidney function.
  Omar Mamlouk, Paolo Strati, Lei Feng, Ryan Sun, Amy Ayers, Raphael E Steiner, Ranjit Nair, Christopher Flowers, Jeremy L Ramdial, Neeraj Saini, Samer A Srour, Richard ...> ;British Journal of Haematology. 2024 Jan 1
• 1 citations
  High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma.
  Hanan Alkhaldi, Alec Reinhardt, Melissa Barnett, Suprateek Kundu, Chitra Hosing, Jeremy Ramdial, Neeraj Saini, Samer Srour, Amin Alousi, Partow Kebriaei, Uday Popat, M...> ;Transplantation and Cellular Therapy. 2023 Nov 1
• 6 citations
  Prolonged cytopenia following CD19 CAR T cell therapy is linked with bone marrow infiltration of clonally expanded IFNγ-expressing CD8 T cells.
  Paolo Strati, Xubin Li, Qing Deng, Mario L Marques-Piubelli, Jared Henderson, Grace Watson, Laurel Deaton, Taylor Cain, Haopeng Yang, Vida Ravanmehr, Luis E Fayad, Swa...> ;Cell Reports. Medicine. 2023 Aug 15
• 6 citations
  A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma.
  Paolo Strati, Andrew Jallouk, Qing Deng, Xubin Li, Lei Feng, Ryan Sun, Sherry Adkins, Swapna Johncy, Taylor Cain, Raphael E Steiner, Sairah Ahmed, Dai Chihara, Luis E ...> ;Blood Advances. 2023 Nov 14
• 1 citations
  Safety of Concurrent Radiation Therapy With Brentuximab Vedotin in the Treatment of Lymphoma.
  Susan Y Wu, Penny Q Fang, Ethan B Wang, Sairah Ahmed, Madeleine Duvic, Preetesh Jain, Luis E Malpica Castillo, Ranjit Nair, Raphael E Steiner, Paolo Strati, Auris O Hu...> ;Advances in Radiation Oncology. 2023 Jun 2
• 42 citations
  A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy.
  Christoph K Stein-Thoeringer, Neeraj Y Saini, Eli Zamir, Viktoria Blumenberg, Maria-Luisa Schubert, Uria Mor, Matthias A Fante, Sabine Schmidt, Eiko Hayase, Tomo Hayas...> ;Nature Medicine. 2023 Apr 1
• 4 citations
  CD30 expression is frequently decreased in relapsed classic Hodgkin lymphoma after anti-CD30 CAR T-cell therapy.
  Mario L Marques-Piubelli, Do Hwan Kim, L Jeffrey Medeiros, Wei Lu, Khaja Khan, Lorena Isabel Gomez-Bolanos, Saxon Rodriguez, Edwin R Parra, Chi Young Ok, Akanksha Arad...> ;Histopathology. 2023 Jul 1
• 1 citations
  PD-L1macrophages are associated with favorable features in primary mediastinal (thymic) large B-cell lymphoma.
  Raphael E Steiner, Edwin R Parra, Francisco Vega, Lei Feng, Jason R Westin, Sattva S Neelapu, Paolo Strati, Michael R Green, Christopher R Flowers, Luisa M Solis, Igna...> ;Experimental Hematology & Oncology. 2023 Mar 20
• 15 citations
  Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma.
  Jason Westin, R Eric Davis, Lei Feng, Fredrick Hagemeister, Raphael Steiner, Hun Ju Lee, Luis Fayad, Loretta Nastoupil, Sairah Ahmed, Alma Rodriguez, Michelle Fanale, ...> ;Journal of Clinical Oncology. 2023 Feb 1
• 4 citations
  Positron emission tomography derived metrics in relapsed or refractory large B-cell lymphoma with residual disease before autologous stem cell transplant.
  Cherng, H., Xu, G., Feng, L., Steiner, R., Fayad, L., Strati, P., Nair, R., Nastoupil, L., Lee, H., Neelapu, S., Flowers, C., Rodriguez, M., Wang, M., Hagemeister, F.,...> ;British Journal of Haematology. 2023 Jan 1
• 8 citations
  Impact of conditioning chemotherapy on lymphocyte kinetics and outcomes in LBCL patients treated with CAR T-cell therapy.
  Paolo Strati, Andrew P Jallouk, Ryan Sun, Jaihee Choi, Kaberi Das, Hua-Jay Cherng, Sairah Ahmed, Hun J Lee, Swaminathan P Iyer, Ranjit Nair, Loretta J Nastoupil, Rapha...> ;Leukemia. 2022 Nov 1
• 19 citations
  Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression.
  Guangchun Han, Qing Deng, Mario L Marques-Piubelli, Enyu Dai, Minghao Dang, Man Chun John Ma, Xubin Li, Haopeng Yang, Jared Henderson, Olga Kudryashova, Mark Meerson, ...> ;Blood Cancer Discovery. 2022 Sep 6
• 18 citations
  Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphoma.
  Hua-Jay J Cherng, Ryan Sun, Bryant Sugg, Russell Irwin, Haopeng Yang, Cao Cuong Le, Qing Deng, Luis Fayad, Nathan H Fowler, Simrit Parmar, Raphael Steiner, Fredrick Ha...> ;Blood. 2022 Aug 4
• Second malignancies in patients with Hodgkin's Lymphoma: Half a century of experience.
  Bouthaina Shbib Dabaja, David Boyce-Fappiano, Wenli Dong, Ethan Damron, Penny Fang, Jill Gunther, Maria A Rodriguez, Paolo Strati, Raphael Steiner, Hun Lee, Zeinab Abo...> ;Clinical and Translational Radiation Oncology. 2022 Jul 1
• 13 citations
  Cardiovascular events in patients treated with chimeric antigen receptor t-cell therapy for aggressive B-cell lymphoma.
  Raphael E Steiner, Jose Banchs, Efstratios Koutroumpakis, Melody R. Becnel, Cristina Gutierrez, Paolo Strati, Chelsea C. Pinnix, Lei Feng, Gabriela Rondon, Catherine M...> ;Haematologica. 2021 Nov 11
• 3 citations
  A prospective study on early PET/CT scans during the first cycle of salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma.
  Hua Jay J. Cherng, Hubert H. Chuang, Raphael E Steiner, Luis Fayad, Paolo Strati, Fredrick B. Hagemeister, Loretta J. Nastoupil, Hun Ju Lee, Sattva S. Neelapu, Christo...> ;Leukemia & Lymphoma. 2021 Aug 26
• 52 citations
  CRP and ferritin in addition to the EASIX score predict CAR-T-related toxicity.
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Blood Advances. 2021 Jul 27
• 29 citations
  Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma.
  Shaojun Zhang, Vivian Changying Jiang, Guangchun Han, Dapeng Hao, Junwei Lian, Yang Liu, Rongjia Zhang, Joseph McIntosh, Ruiping Wang, Minghao Dang, Enyu Dai, Yuanxin ...> ;Nature Communications. 2021 May 17
• 8 citations
  Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis.
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Haematologica. 2021 May 6
• Prognostic value of disease distribution in secondary central nervous system diffuse large B cell lymphoma treated with radiation therapy.
  , , , , , , , , , , , , , , , , , , , > ;Leukemia & Lymphoma. 2021 May 4
• 6 citations
  Outcome of relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: a North American analysis
  Paolo Strati, Phoebe T M Cheng, Raphael E Steiner, Pedro E Alcedo Andrade, Lei Feng, Dahlia Sano, Veeramaneni A Rao, Prachee Singh, Roberto N. Miranda, Jillian R. Gunt...> ;British Journal of Haematology. 2021 Feb 1
• 4 citations
  The impact of cell-of-origin, MYC/Bcl-2 dual expression and MYC rearrangement on disease relapse among early stage diffuse large B-cell lymphoma patients treated with ...
  , , , , , , , , , , , , , , , , , , , , , > ;Leukemia & Lymphoma. 2021 Jan 22
• Join now to see all

Abstracts/Posters

• Non-Bcl2 Mutations Are Predominant in Patients (pts) with Venetoclax Resistant Mantle Cell Lymphoma (MCL) _ Response and Clinical Outcomes in Ultra-Refractory MCL
  Raphael Eric Steiner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Radiation Therapy Can be an Effective Bridging Strategy Prior to Axicabtagene Ciloleucel Therapy for Relapsed/Refractory Large B-Cell LymphomaRadiation Therapy Can be ...
  Raphael E Steiner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• A Phase II Clinical Trial of Cpi-613 (devimistat) in Patients with Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma with Rearrangements o...
  Raphael Eric Steiner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Clinical and Radiological Correlates of Neurotoxicity after Standard of Care Axicabtagene Ciloleucel in Patients with Relapsed/Refractory Large B-Cell Lymphoma
  Raphael Eric Steiner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Smart Start: Rituximab, Lenalidomide, and Ibrutinib Alone and in Combination with Standard Chemotherapy for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma...
  Raphael Eric Steiner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• A Phase II Trial of Nivolumab and Ibrutinib for Patients with Relapsed or Refractory Central Nervous System Lymphoma
  Raphael E Steiner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Results of a Phase II Study of Obinutuzumab in Combination with Lenalidomide in Previously Untreated, High Tumor Burden Follicular Lymphoma (FL)
  Raphael E Steiner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Frontline Treatment with Ibrutinib with Rituximab (IR) Combination Is Highly Effective in Elderly (_65 years) Patients with Mantle Cell Lymphoma (MCL) _ Results from a...
  Raphael Eric Steiner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Clinical and Radiological Correlates of Neurotoxicity after Standard of Care Axicabtagene Ciloleucel in Patients with Relapsed/Refractory Large B-Cell Lymphoma
  Raphael Eric Steiner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• A Phase II Trial of Nivolumab and Ibrutinib for Patients with Relapsed or Refractory Central Nervous System Lymphoma
  Raphael E Steiner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Comparative Review of 30 Day Non-Relapse Mortality (NRM) in B-Cell Lymphomas Associated with Anti-CD19 Chimeric Antigen Receptor T-Cells (CAR-T) from FDA Database, Cli...
  Raphael E Steiner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• Safety of Axicabtagene Ciloleucel CD19 CAR T-Cell Therapy in Elderly Patients with Relapsed or Refractory Large B-Cell Lymphoma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018